Ligand validation:6QKK

PO4: PHOSPHATE ION

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6QKK_PO4_E_303	86%	62%	0.105	0.975	0.92	0.55	-	-	0	0	100%	1
6QKK_PO4_F_402	85%	62%	0.108	0.974	0.89	0.57	-	-	0	0	100%	1
6QKK_PO4_I_402	79%	66%	0.125	0.972	0.89	0.45	-	-	0	0	100%	1
6QKK_PO4_A_402	77%	58%	0.133	0.972	0.83	0.8	-	-	0	0	100%	1
6QKK_PO4_H_402	73%	62%	0.136	0.964	0.91	0.56	-	-	0	0	100%	1
6QKK_PO4_D_402	72%	64%	0.155	0.981	0.83	0.56	-	-	0	0	100%	1
6QKK_PO4_G_402	71%	61%	0.149	0.972	0.93	0.59	-	-	0	0	100%	1
6QKK_PO4_C_402	70%	65%	0.152	0.969	1	0.35	-	-	0	0	100%	1
6QKK_PO4_B_406	53%	63%	0.184	0.947	0.84	0.59	-	-	0	0	100%	1
6QKK_PO4_J_303	30%	65%	0.261	0.924	0.89	0.47	-	-	0	0	100%	1
6QQO_PO4_B_302	90%	59%	0.101	0.983	0.95	0.62	-	-	0	0	100%	1
2YME_PO4_E_1208	84%	67%	0.106	0.967	0.87	0.43	-	-	0	0	100%	1
6T9R_PO4_FFF_305	80%	59%	0.121	0.969	1.14	0.47	1	-	0	0	100%	1
2XZ5_PO4_B_1213	61%	22%	0.158	0.948	2.36	0.93	1	-	0	0	100%	1
1AQZ_PO4_A_400	100%	5%	0.017	0.995	3.38	1.91	3	2	0	0	100%	0.976
1FXF_PO4_A_292	100%	31%	0.028	0.999	1.81	0.98	2	-	0	0	100%	1
1L8S_PO4_A_316	100%	26%	0.025	0.997	2.16	0.88	1	-	0	0	100%	1
1T36_PO4_E_1078	100%	13%	0.026	0.997	2.59	1.39	3	1	0	0	100%	1
2PI8_PO4_B_696	100%	44%	0.018	0.998	1.73	0.46	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.